← Back to list
FundsmithFund report30 Jun 2023Source: fundsmith.co.uk

Fundsmith Equity Fund Interim Report 2023

Fundsmith is the fund firm Terry Smith ("Britain's Warren Buffett") founded in 2010, with a discipline of radical simplicity — Buy Good Companies, Don't Overpay, Do Nothing: a concentrated book of 20-30 high-ROCE global consumer, healthcare and tech franchises with near-zero turnover. His annual shareholder letters are famous for wit and common sense; peak AUM topped £25bn.

Terry Smith · 2010 · 英国伦敦Quality growth / Concentrated

In plain words

This report breaks down the Fundsmith Equity Fund's first-half 2023 results. The fund returned 8.5%, slightly behind the global stock market. The manager sold Amazon and Adobe, worried about wasteful investments (i.e., moving into low-return businesses outside their core), and bought Procter & Gamble and Unilever. For everyday investors, it's a reminder to focus on companies that stick to their strengths. Worth reading for a glimpse into a pro's disciplined approach—no macro bets, just quality.

AI SummaryAI-generated · may contain errors · verify against the original

In the first half of 2023, the Fundsmith Equity Fund (T Class Acc) rose by 8.5%, slightly underperforming the MSCI World Index's 8.9%. The most notable portfolio moves during this period were the complete liquidation of Amazon and Adobe, as manager Terry Smith expressed concerns over their capital a

~5 min full read · 5 sections
Deep Analysis

Period Performance

Metric H1 2023 Since Inception (Cumulative) Since Inception (Annualized)
Fundsmith Equity Fund (T Class Acc) +8.5% +527.1% +15.6%
MSCI World Index (£ Net) +8.9% +288.5% +11.3%
UK Bonds (5-10 Year) -3.4% +15.7% +1.2%
Cash (£ Rate) +2.0% +10.0% +0.8%

Note: The fund does not reference any benchmark; the above is provided for comparative reference.

Top Ten Holdings

The report does not disclose a complete list of the top ten holdings, only providing geographic and sector distributions.

Geographic Distribution (by Listing Location)

Region June 30, 2023 December 31, 2022
United States 69% 72%
Europe 26% 23%
United Kingdom 5% 5%

Sector Distribution

Sector June 30, 2023 December 31, 2022
Consumer Staples 34% 34%
Healthcare 25% 26%
Consumer Discretionary 11% 12%
Information Technology 10% 10%
Communication Services 8% 4%
Industrials 5% 6%
Financials 4% 4%
Other Net Assets 3% 4%

Key Buys and Sells This Period

Largest Buys (by Cost)

Company Cost (£)
Procter & Gamble 497,938,082
Unilever 260,406,885
Apple 96,180,025
Church & Dwight 90,161,117
Visa 25,131,509
LVMH 20,165,476

Largest Sells (by Proceeds)

Company Proceeds (£)
Adobe 551,281,458
Amazon 525,254,260
Church & Dwight 198,223,741
IDEXX Laboratories 186,005,801
Estée Lauder 55,079,981

Notable Actions Mentioned in Manager Commentary:

  • Liquidated: Amazon (due to concerns over capital allocation), Adobe (similar rationale)
  • New positions: Procter & Gamble, Unilever (both are new holdings)

Fees and Size

Item Value
Total Fund Size (T Class Acc+Inc+R Class Acc+Inc+I Class Acc+Inc) £23,606,379,278
OCF (T Class Acc) 1.04%
OCF (I Class Acc) 0.94%
OCF (R Class Acc) 1.54%
Portfolio Turnover (H1 2023) 6.2%
Voluntary Transaction Costs (H1 2023) £1,192,657 (0.005% or 0.5 basis points)
Total Investment Cost (T Class Acc, incl. transaction costs) 1.06%
Dividend (T Class Acc, per share) 0.52p

Key Points from Manager Commentary

1. Performance Attribution: The top five positive contributors were Meta (+3.1%), Microsoft (+2.6%), L'Oréal (+1.5%), LVMH (+1.1%), and Amadeus (+1.0%); the top five detractors were Waters (-1.2%), Estée Lauder (-1.2%), ADP (-0.6%), Mettler-Toledo (-0.4%), and Philip Morris (-0.4%).

2. Rationale for Liquidation: The sales of Amazon and Adobe were driven by concerns over capital allocation errors — Amazon's CEO announced an entry into grocery retail, contradicting the firm's own stated investment principles; the manager notes that companies deviating from core strengths into low-return areas typically destroy value.

3. Current Fundamentals: Revenue growth for technology companies has slowed (Microsoft from 18% to approximately 7%, Meta from >20% to about 8%); healthcare companies have performed steadily (Stryker up 13%, Novo Nordisk up 25% driven by weight-loss drug Wegovy); consumer goods companies face input cost pressures (P&G gross margin fell from 50% to 47%, Estée Lauder from 80% to 72%).

4. Valuation Changes: The portfolio's free cash flow yield declined from 3.2% at end-2022 to approximately 2.8% at end-June 2023, due to rising share prices and impaired cash flow conversion; the portfolio's valuation has exceeded that of the S&P 500 Index.

5. Macro Stance: The manager explicitly states that investments are not based on macroeconomic or geopolitical forecasts (no views on interest rates, recession, Ukraine, or Taiwan issues), and insists on holding high-quality companies for the long term, relying on their intrinsic compounding ability to determine long-term performance.